GB0524427D0 - Use of receptor ligands in threapy - Google Patents

Use of receptor ligands in threapy

Info

Publication number
GB0524427D0
GB0524427D0 GBGB0524427.2A GB0524427A GB0524427D0 GB 0524427 D0 GB0524427 D0 GB 0524427D0 GB 0524427 A GB0524427 A GB 0524427A GB 0524427 D0 GB0524427 D0 GB 0524427D0
Authority
GB
United Kingdom
Prior art keywords
threapy
receptor ligands
ligands
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0524427.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
7TM Pharma AS
Original Assignee
7TM Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 7TM Pharma AS filed Critical 7TM Pharma AS
Priority to GBGB0524427.2A priority Critical patent/GB0524427D0/en
Publication of GB0524427D0 publication Critical patent/GB0524427D0/en
Priority to PCT/EP2006/011384 priority patent/WO2007062797A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
GBGB0524427.2A 2005-11-30 2005-11-30 Use of receptor ligands in threapy Ceased GB0524427D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0524427.2A GB0524427D0 (en) 2005-11-30 2005-11-30 Use of receptor ligands in threapy
PCT/EP2006/011384 WO2007062797A1 (en) 2005-11-30 2006-11-23 Amino-substituted azo-heterocyclic compounds for treating inflammatory conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0524427.2A GB0524427D0 (en) 2005-11-30 2005-11-30 Use of receptor ligands in threapy

Publications (1)

Publication Number Publication Date
GB0524427D0 true GB0524427D0 (en) 2006-01-11

Family

ID=35685791

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0524427.2A Ceased GB0524427D0 (en) 2005-11-30 2005-11-30 Use of receptor ligands in threapy

Country Status (2)

Country Link
GB (1) GB0524427D0 (en)
WO (1) WO2007062797A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010053902A2 (en) * 2008-11-04 2010-05-14 Herbalscience Group, Llc Tryptase enzyme inhibiting aminothiophenols
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
EP2526945A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. New CRTH2 Antagonists
EP2548876A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists
EP2548863A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists.
US20140328861A1 (en) 2011-12-16 2014-11-06 Atopix Therapeutics Limited Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic Esophagitis
CN105130725B (en) * 2015-08-05 2018-06-29 苏州大学 A kind of method for preparing γ -one carbonyl complexs
CN107556287B (en) * 2017-09-01 2018-06-26 连云港恒运药业有限公司 Canagliflozin intermediate synthetic method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07118247A (en) * 1993-10-26 1995-05-09 Yamanouchi Pharmaceut Co Ltd Thiazoleacetic acid derivative
JPH07149746A (en) * 1993-11-30 1995-06-13 Hisamitsu Pharmaceut Co Inc New 2-substituted aminothiazole derivative
JPH07149745A (en) * 1993-11-30 1995-06-13 Hisamitsu Pharmaceut Co Inc New 2-aminothiazole derivative
AU726058B2 (en) * 1995-09-01 2000-10-26 Signal Pharmaceuticals, Inc. Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
US7371759B2 (en) * 2003-09-25 2008-05-13 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method

Also Published As

Publication number Publication date
WO2007062797A1 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
IL190587A0 (en) Substituted benzofused derivatives and their use as vanilliod receptor ligands
GB0522715D0 (en) New use
GB0512940D0 (en) Compounds and their use
GB0524428D0 (en) Medicinal use of receptor ligands
GB0520743D0 (en) Compounds and their use
GB0524427D0 (en) Use of receptor ligands in threapy
GB0520176D0 (en) Use
GB0511190D0 (en) Use
GB0418540D0 (en) Use
GB0526552D0 (en) New use
GB0502250D0 (en) Use
EP2067480A4 (en) Musclin receptor and use thereof
GB0526031D0 (en) Use
GB0526032D0 (en) Use
GB0407301D0 (en) Use
GB0410015D0 (en) Use
EP2016949A4 (en) Novel use of g-protein-conjugated receptor and ligand thereof
GB0412878D0 (en) Use
GB0508924D0 (en) New use
GB0516610D0 (en) Compounds for use in therapy
GB0424494D0 (en) Use
GB0515322D0 (en) Ligands and use thereof
GB0503950D0 (en) Use
GB0507986D0 (en) Use
GB0507874D0 (en) Use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)